Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blood Markers in Diabetic Peripheral Neuropathy
NCT06041399Phase 4Unknown
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Feb 2012
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 4 trial (4 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoints: severity of diabetic peripheral neuropathy at 1 week and presence of diabetic peripheral neuropathy at 1 week. Status: unknown.
Beyond the preview
Go deeper on NCT06041399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06041399.